Episode 59
Biotech Hangout
00:00
EQRX: A Biotech Company That Has Lost Their Mandatory and Investor Mandate
EQRX was not necessarily a great one to have in the mix, even though there might have been a noble element to what they were trying to do. Dafy says it's incredibly difficult for these type of companies to turn on the dime and become an acquisition machine. "What we as an industry do well is great science and innovation, not, you know, smart business models"
Transcript
Play full episode
